Searle & Co. Bristol Myers Squibb CO Transaction History
Searle & Co.
- $346 Million
- Q1 2025
A detailed history of Searle & Co. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Searle & Co. holds 84,510 shares of BMY stock, worth $4.02 Million. This represents 1.49% of its overall portfolio holdings.
Number of Shares
84,510
Previous 84,510
-0.0%
Holding current value
$4.02 Million
Previous $4.78 Million
7.85%
% of portfolio
1.49%
Previous 1.4%
Shares
18 transactions
Others Institutions Holding BMY
# of Institutions
2,811Shares Held
1.59BCall Options Held
25.9MPut Options Held
23.9M-
Vanguard Group Inc Valley Forge, PA191MShares$9.09 Billion0.22% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.54 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$5.13 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.8MShares$4.51 Billion0.24% of portfolio
-
Capital International Investors Los Angeles, CA66.5MShares$3.16 Billion0.83% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $101B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...